Tumor microenvironment and metabolic remodeling in gemcitabine‐based chemoresistance of pancreatic cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference106 articles.
1. Cancer statistics, 2020;Siegel;CA: a cancer journal for clinicians,2020
2. Pancreatic cancer;Mizrahi;Lancet,2020
3. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N. Engl. J. Med.,2018
4. Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer;Catenacci;J. Clin. Oncol.,2015
5. Chemoresistance in pancreatic cancer;Zeng;Int. J. Mol. Sci.,2019
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma;Cancer Letters;2024-08
2. Delivery of piperlongumine via hyaluronic acid/phenylboronic acid-mediated dual targetable polymersome for enhanced anticancer functionality against pancreatic tumor;International Journal of Biological Macromolecules;2024-08
3. The solvation process and thermodynamic parameters analysis of gemcitabine form a in pure and mixed solvents;Journal of Molecular Liquids;2024-06
4. The nuclear export protein exportin‐1 in solid malignant tumours: From biology to clinical trials;Clinical and Translational Medicine;2024-05
5. Chemotherapy Assessment in Advanced Multicellular 3D Models of Pancreatic Cancer: Unravelling the Importance of Spatiotemporal Mimicry of the Tumor Microenvironment;Advanced Biology;2024-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3